Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cellsSara A. Byron, Douglas Yee|British Journal of Cancer|2006Cited by 118
Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN statusSara A. Byron, Pamela M. Pollock|Molecular Cancer|2012Cited by 45
Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast CancerMarc A. Becker, Douglas Yee, Yasir H. Ibrahim et al.|PLoS ONE|2016Cited by 15
Abstract 4706: Evaluating the efficacy of RAS(ON) inhibitor RMC-6236 combined with chemotherapy and other targeted therapies in 3D models involving patients with KRAS-mutated pancreatic cancerTaylor Bargenquast, Sunil Sharma, Tithi Ghosh et al.|Cancer Research|2025Cited by 1